Troubling news from Asia about treating enteric fever: a coming storm
In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should...
Enregistré dans:
Auteur principal: | Ryan, Edward T |
---|---|
Format: | Technical Report |
Langue: | en_US |
Publié: |
Lancet Infect Dis 2016
2016
|
Sujets: | |
Accès en ligne: | http://103.69.126.140:8080/handle/123456789/817 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomized controlled trial
par: Arjyal, Amit, et autres
Publié: (2016) -
Study on incidence of Nalidixic acid resistant Salmonella enterica serovar Typhi and Salmonella entrica serovar Paratyphi A and their antibiotic susceptibilities.
par: Giri, Shudij
Publié: (2012) -
Control of yellow fever Field Guide
Publié: (2005) -
Frequently asked questions on chikungunya fever
Publié: (2013) -
Knowledge, attitude and practice regarding dengue fever among the healthy population of highland and lowland communities in central Nepal.
par: Dhimal, Meghnath Aryal, Krishna Kumar Dhimal, Mandira Lamichhane Gautam, Ishan Singh, Shanker Pratap Bhusal, Chop Lal Kuch, Ulrich
Publié: (2014)